Comentarios al consenso ESC 2018 sobre la cuarta definición universal del infarto de miocardio

Sambola, Antonia; Viana-Tejedor, Ana; Bueno, Héctor; Barrabes, A.; Delgado, Victoria; Jiménez, Pilar; Pérez, Pablo Jorge; Noriega, Francisco J.; Vilà, Montserrat; Aboal, Jaime; Bouzas, Alberto; Brugaletta, Salvatore; Durán, Albert Borau i; Diego, José Juan Gómez de; Hernández, Felipe; López, Teresa; Lozano, Íñigo; Núñez, Iván; Ojeda, Soledad; Rosillo, Sandra; Sanchís, Juan; Alfonso, Fernándo; Ibáñez, Borja; Arribas, Fernando; Congost, Gemma Berga; Evangelista, Arturo; Ferreira‐González, Ignacio; Navarro, Manuel Jiménez; Marı́n, Francisco; Isla, Leopoldo Pérez de; Vázquez, Rafael

doi:10.1016/j.recesp.2018.11.009

Cited by 3 publications

(2 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…2 De acuerdo con el consenso de la Sociedad Europea de Cardiología y la cuarta definición universal de infarto de 2018, la ECV se define como la presencia de daño miocárdico agudo detectado por la elevación de biomarcadores cardiacos que evidencian isquemia miocárdica aguda. 3 La intervención coronaria percutánea primaria (ICPP) se realiza en el contexto del infarto agudo del miocardio con elevación del segmento ST (IAMCEST) sin tratamiento fibrinolítico previo; constituye la estrategia de reperfusión preferida. La ICPP ha reemplazado a la fibrinólisis como tratamiento del IAMCEST, siempre que se realice en el momento oportuno.…”

Section: Introductionunclassified

Coronary stent and prolonged dual antiplatelet therapy. A longitudinal study

Dámazo-Escobedo

Vieyra-Herrera

Martínez-Ríos

et al. 2022

GMM

View full text Add to dashboard Cite

Introducción: En las guías actuales europeas para el manejo del infarto de miocardio posterior a la colocación de endoprótesis coronaria (stent), no existe consenso sobre la duración ideal de la terapia antiagregante plaquetaria dual (DAPT, dual antiplatelet therapy) para prevenir la trombosis-reestenosis del stent sin aumentar el riesgo significativo de sangrado. Objetivo: Reportar el porcentaje de sangrado mayor y de eventos cardiovasculares mayores asociados a la DAPT prolongada en pacientes atendidos en el Instituto Nacional de Cardiología y tratados con intervención coronaria percutánea primaria y stent. Métodos: Se realizó un estudio longitudinal, prospectivo observacional y descriptivo no experimental. Los pacientes fueron captados de noviembre de 2016 a diciembre de 2017. Resultados: Fueron seleccionados 135 pacientes con una media de edad de 57 ± 10 años, quienes cumplieron un seguimiento clínico por tres años. La obesidad y la hipertensión destacaron como principales factores de riesgo. Posterior al uso de DAPT durante tres años, se registró 3.7 % de mortalidad, 1.48 % de sangrado mayor y 4.4 % de trombosis-reestenosis. Conclusiones: El uso prolongado de DAPT estaría justificado por la alta incidencia de trombosis-reestenosis, sin incremento significativo en el riesgo de sangrado y con disminución de los eventos cardiovasculares mayores.

show abstract

Section: Introductionunclassified

Coronary stent and prolonged dual antiplatelet therapy. A longitudinal study

Dámazo-Escobedo

Vieyra-Herrera

Martínez-Ríos

et al. 2022

GMM

View full text Add to dashboard Cite

show abstract

“…2 According to the European Society of Cardiology consensus and 2018 fourth universal definition of myocardial infarction, CVD is defined as the presence of acute myocardial injury detected by cardiac biomarkers elevation that indicate acute myocardial ischemia. 3 Primary percutaneous coronary intervention (PPCI) is performed in the context of acute ST-segment elevation myocardial infarction (STEMI) without prior fibrinolytic treatment; it is the preferred reperfusion strategy. PPCI has replaced fibrinolysis as a treatment for acute STEMI, provided it is timely performed.…”

Section: Introductionmentioning

confidence: 99%

Endoprótesis coronaria y doble terapia antiplaquetaria prolongada. Un estudio longitudinal

Dámazo-Escobedo¹,

Vieyra-Herrera²,

Martínez-Ríos³

et al. 2022

GMM

View full text Add to dashboard Cite

Introduction:In current European guidelines for the management of myocardial infarction after coronary stent placement, there is no consensus on dual antiplatelet therapy (DAPT) ideal duration to prevent stent thrombosis-restenosis without significantly increasing the bleeding risk. Objective: To report the percentage of major bleeding and presence of major cardiovascular events associated with prolonged DAPT in patients recruited at the National Institute of Cardiology, treated with primary percutaneous coronary intervention and stent. Methods: A longitudinal, prospective, observational, non-experimental, descriptive study was carried out. Patients were recruited from November 2016 to December 2017. Results: One hundred and thirty-five patients with a mean age of 57 ± 10 years who completed the three-year follow-up were selected. Obesity and hypertension stood out as the main risk factors. After using DAPT for three years, 3.7% of mortality, 1.48% of major bleeding, and 4.4% of thrombosis-restenosis were recorded. Conclusions: Prolonged use of DAPT would be justified by the high incidence of thrombosis-restenosis, without a significant increase in bleeding risk, as well as a decrease in major cardiovascular events.

show abstract

The low accuracy of the non-ST-elevation myocardial infarction electrocardiograph criteria of the fourth universal definition of myocardial infarction

Morris

Reynard

Body

2019

Hong Kong Journal of Emergency Medicine

View full text Add to dashboard Cite

Background: The electrocardiograph has been integral to the diagnosis of acute coronary syndromes since the mid-20th Century and is an important initial investigation that chest pain patients undergo on presentation to the Emergency Department. The Fourth Universal Definition of Myocardial Infarction recommends using dichotomous cut-offs to identify ischaemic electrocardiographs. Objectives: We aimed to summarise the existing knowledge to inform emergency clinicians about the diagnostic accuracy of the new guidelines. Methods: We performed a systematic review and a narrative analysis due to the heterogeneity of the studies. Results: We were able to obtain diagnostic characteristics for 10 papers. The ST-depression criteria were highly specific but poorly sensitive in five papers, with a specificity of 97.2%–99.3% and a sensitivity of 16.6%–20.0%. The remaining papers reported a higher sensitivity of 25.7%–58.6% but a lower specificity of 86.0%–91.2%. T wave inversion demonstrated poor specificity; the papers that looked at 0.1 mV T wave inversion demonstrated a sensitivity of 26.9%–46.8% and a specificity of 68.6%–86.4%. Conclusion: The heterogeneous evidence database demonstrates that the Fourth universal definition’s diagnostic performance varies wildly. Apart from two outlying papers, ST-depression has suboptimal sensitivity but high specificity. T wave inversion appears to be more sensitive yet less specific.

show abstract

Comentarios al consenso ESC 2018 sobre la cuarta definición universal del infarto de miocardio

Cited by 3 publications

References 17 publications

Coronary stent and prolonged dual antiplatelet therapy. A longitudinal study

Coronary stent and prolonged dual antiplatelet therapy. A longitudinal study

Endoprótesis coronaria y doble terapia antiplaquetaria prolongada. Un estudio longitudinal

The low accuracy of the non-ST-elevation myocardial infarction electrocardiograph criteria of the fourth universal definition of myocardial infarction

Contact Info

Product

Resources

About